400 related articles for article (PubMed ID: 24300416)
21. Cutoff point for exhaled nitric oxide corresponding to 3% sputum eosinophils.
Alvarez-Puebla MJ; Olaguibel Rivera JM; Almudevar E; Echegoyen AA; de Esteban Chocarro B; Cambra K
J Investig Allergol Clin Immunol; 2015; 25(2):107-11. PubMed ID: 25997303
[TBL] [Abstract][Full Text] [Related]
22. Airway inflammation assessed by invasive and noninvasive means in severe asthma: eosinophilic and noneosinophilic phenotypes.
Lemière C; Ernst P; Olivenstein R; Yamauchi Y; Govindaraju K; Ludwig MS; Martin JG; Hamid Q
J Allergy Clin Immunol; 2006 Nov; 118(5):1033-9. PubMed ID: 17088126
[TBL] [Abstract][Full Text] [Related]
23. Increased YKL-40 and Chitotriosidase in Asthma and Chronic Obstructive Pulmonary Disease.
James AJ; Reinius LE; Verhoek M; Gomes A; Kupczyk M; Hammar U; Ono J; Ohta S; Izuhara K; Bel E; Kere J; Söderhäll C; Dahlén B; Boot RG; Dahlén SE;
Am J Respir Crit Care Med; 2016 Jan; 193(2):131-42. PubMed ID: 26372680
[TBL] [Abstract][Full Text] [Related]
24. Immunological biomarkers in severe asthma.
Narendra D; Blixt J; Hanania NA
Semin Immunol; 2019 Dec; 46():101332. PubMed ID: 31735516
[TBL] [Abstract][Full Text] [Related]
25. Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma.
Agrawal S; Townley RG
Expert Opin Biol Ther; 2014 Feb; 14(2):165-81. PubMed ID: 24283478
[TBL] [Abstract][Full Text] [Related]
26. Serum periostin in smokers and never smokers with asthma.
Thomson NC; Chaudhuri R; Spears M; Haughney J; McSharry C
Respir Med; 2015 Jun; 109(6):708-15. PubMed ID: 25869478
[TBL] [Abstract][Full Text] [Related]
27. Exploring the effects of omalizumab in allergic asthma: an analysis of biomarkers in the EXTRA study.
Hanania NA; Wenzel S; Rosén K; Hsieh HJ; Mosesova S; Choy DF; Lal P; Arron JR; Harris JM; Busse W
Am J Respir Crit Care Med; 2013 Apr; 187(8):804-11. PubMed ID: 23471469
[TBL] [Abstract][Full Text] [Related]
28. Periostin as a biomarker for the diagnosis of pediatric asthma.
Inoue T; Akashi K; Watanabe M; Ikeda Y; Ashizuka S; Motoki T; Suzuki R; Sagara N; Yanagida N; Sato S; Ebisawa M; Ohta S; Ono J; Izuhara K; Katsunuma T
Pediatr Allergy Immunol; 2016 Aug; 27(5):521-6. PubMed ID: 27062336
[TBL] [Abstract][Full Text] [Related]
29. Novel biomarkers for asthma stratification and personalized therapy.
Bartminski G; Crossley M; Turcanu V
Expert Rev Mol Diagn; 2015 Mar; 15(3):415-30. PubMed ID: 25479456
[TBL] [Abstract][Full Text] [Related]
30. Decreased epithelial and sputum miR-221-3p associates with airway eosinophilic inflammation and CXCL17 expression in asthma.
Zhang K; Liang Y; Feng Y; Wu W; Zhang H; He J; Hu Q; Zhao J; Xu Y; Liu Z; Zhen G
Am J Physiol Lung Cell Mol Physiol; 2018 Aug; 315(2):L253-L264. PubMed ID: 29644894
[TBL] [Abstract][Full Text] [Related]
31. Identification of airway mucosal type 2 inflammation by using clinical biomarkers in asthmatic patients.
Silkoff PE; Laviolette M; Singh D; FitzGerald JM; Kelsen S; Backer V; Porsbjerg CM; Girodet PO; Berger P; Kline JN; Chupp G; Susulic VS; Barnathan ES; Baribaud F; Loza MJ;
J Allergy Clin Immunol; 2017 Sep; 140(3):710-719. PubMed ID: 28089872
[TBL] [Abstract][Full Text] [Related]
32. Relevance of TH2 Markers in the Assessment and Therapeutic Management of Severe Allergic Asthma: A Real-Life Perspective.
Caminati M; Vianello A; Chieco Bianchi F; Festi G; Guarnieri G; Marchi MR; Micheletto C; Olivieri M; Tognella S; Guerriero M; Senna G;
J Investig Allergol Clin Immunol; 2020; 30(1):35-41. PubMed ID: 30676321
[TBL] [Abstract][Full Text] [Related]
33. Biomarkers and asthma management: an update.
Bayes HK; Cowan DC
Curr Opin Allergy Clin Immunol; 2016 Jun; 16(3):210-7. PubMed ID: 27057795
[TBL] [Abstract][Full Text] [Related]
34. Association of airway wall thickness with serum periostin in steroid-naive asthma.
Hoshino M; Ohtawa J; Akitsu K
Allergy Asthma Proc; 2016 May; 37(3):225-30. PubMed ID: 27178891
[TBL] [Abstract][Full Text] [Related]
35. Noninvasive biomarkers that predict treatment benefit from biologic therapies in asthma.
Arron JR; Choy DF; Scheerens H; Matthews JG
Ann Am Thorac Soc; 2013 Dec; 10 Suppl():S206-13. PubMed ID: 24313774
[TBL] [Abstract][Full Text] [Related]
36. Inflammometry in pediatric asthma: a review of fractional exhaled nitric oxide in clinical practice.
Mahr TA; Malka J; Spahn JD
Allergy Asthma Proc; 2013; 34(3):210-9. PubMed ID: 23462278
[TBL] [Abstract][Full Text] [Related]
37. Diagnostic value of thymus and activation-regulated chemokine and of periostin in eosinophilic asthma: A prospective study.
Yormaz B; Menevse E; Cetin N; Esin Celik Z; Bakir H; Tulek B; Korez MK; Suerdem M
Allergy Asthma Proc; 2021 Jan; 42(1):e30-e39. PubMed ID: 33404399
[No Abstract] [Full Text] [Related]
38. Exhaled nitric oxide levels and blood eosinophil counts independently associate with wheeze and asthma events in National Health and Nutrition Examination Survey subjects.
Malinovschi A; Fonseca JA; Jacinto T; Alving K; Janson C
J Allergy Clin Immunol; 2013 Oct; 132(4):821-7.e1-5. PubMed ID: 23890753
[TBL] [Abstract][Full Text] [Related]
39. Looking for Airways Periostin in Severe Asthma: Could It Be Useful for Clustering Type 2 Endotype?
Carpagnano GE; Scioscia G; Lacedonia D; Soccio P; Lepore G; Saetta M; Foschino Barbaro MP; Barnes PJ
Chest; 2018 Nov; 154(5):1083-1090. PubMed ID: 30336944
[TBL] [Abstract][Full Text] [Related]
40. YKL-40 in induced sputum after allergen bronchial provocation in atopic asthma.
Lee JH; Park KH; Park JW; Hong CS
J Investig Allergol Clin Immunol; 2012; 22(7):501-7. PubMed ID: 23397672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
